The mouse proto-oncogene Pim-1, which encodes two cytoplasmic serine-threonine-specific protein kinases, is frequently activated by proviral insertion in murine leukemia virus-induced hematopoietic tumors. Transgenic mice overexpressing Pim-1 show a low incidence of spontaneous T cell lymphomas, whereas null mutant mice lack an obvious phenotype. We have analyzed the early B lymphoid compartment from both null mutant and El~-Pim-1 transgenic mice. The level of Pim-1 expression appears to be a determining factor in the ability of these cells to respond to the growth factors interleukin 7 (IL-7) and SF (steel factor). The impaired response in null mutant mice could be rescued by introduction of a functional Pim-1 transgene. Moreover, overexpression of Pim-1 facilitates the derivation of primitive lymphoid cell lines that are dependent on combined stimulation with IL-7 and SF or insulin-like growth factor 1. These results for the first time identify the involvement of Pim-1 in a normal cellular function, as an important regulator of early B lymphopoiesis in mice.
T
he Pim-1 gene was originally identified as a common insertion site in Moloney MuLV (MoMuLV)l-induced T cell lymphomas in mice (1, 2) . Subsequently, it has also been found activated in MoMuLV-induced B call lymphomas (3) and Friend virus-induced erythroleukemias (4) .
The mouse Pim-1 gene encodes two proteins by alternative initiation at AUG (34 kD) or CUG (44 kD) . Usage of the latter is not apparent in humans (5) . Although the human protein has been reported to phosphorylate tyrosine residues (6) , more recent data conclusively show that both the mouse (5) and human (5, 7, 8) Pim-1 proteins exclusively exhibit serine/threonine-dependent protein kinase activity. Both proteins are localized in the cytoplasm and are short-lived, with half-life values of 5-10 rain for the 34 kD and '~,45 rain for the 44-kD protein (5) . Both murine and human Pim-1 are predominantly expressed in hematopoietic tissues (9, 10) where mRNA and protein are mitogen inducible (11) (12) (13) .
The gene's oncogenic potential was proven in E/~-Pim-1 transgenic mice, which showed a low inddence of T cell lymphomas (9) . The low incidence and variable latency period indicates that overexpression by itself is insufficient for transformation. This was confirmed by exposing mice to viral 1Abbreviations used in this paper: CFC, colony-forming cell; CM, conditioned medium; IGF-1, insulin-like growth factor; LTC, long-term culture; MoMuLV, Moloney murine leukemia virus; SF, steel factor.
(MoMuLV) or chemical (N-ethyl-N-nitrosourea) carcinogenic agents. In both cases, lymphomas developed much faster in transgenic animals (9, 14) . In nearly all EIz-Pim- 1 tumors, activation of c-myc or n-myr was observed. The capacity of Pim-1 and c-myc to synergize in lymphomagenesis was most convincingly shown in crosses of E/~-myc and E#-Pira-1 transgenic mice. Coexpression of both transgenes caused the development ofpre-B cell leukemias in utero (15) , making this the strongest cooperation seen between two oncogenes in vivo to date.
Pim-1 is highly conserved between mammals (2, 10, (16) (17) (18) . Null mutants, however, display a surprisingly limited phenotype (19, 20) apart from an impaired IL-3 response (21) . As our earlier studies showed that Pira-1 can predispose to pre-B cell neoplasias, we have analyzed the early B lymphoid compartment from bone marrow of mice expressing different levels of Pim-1. Expression level-dependent differences were indeed detected.
Materials and Methods
Mutant Pim-I Mice. The Pim-1 null mutants, lacking part of the coding region, were as described before (21) . The null alleles were maintained on a 129/Ola (inbred) or a 129/Ola x BALB/c (outbred) background. The Et~-Pim-1 transgenic, founderline 64 mice have also been described before (10) . The transgene consists of a genomic Pim-1 clone with two copies of the Ig E/~ enhancer located upstream of the start site and a MoMuLV LTR in the 3' untranslated region and is highly expressed in lymphoid and myeloid cells. The transgene was introduced into (CBA/BrA x C57BL/LiA)F1 zygotes and the resulting transgenics were backcrossed with (CBA/BrA x C57BL/LiA)F1, C57BL/LiA, or C57BL/6 mice. The WT-Pim-1 transgenic mice, founderline 4550, were made by introduction of an "~11-kb genomic EcoRI fragment of Pim-1 into FVB zygotes. The genotype of all the mutant mice was monitored by Southern analysis of tail-tip DNA, according to Laird et al. (22) .
Protein Analysis. Analysis of the Pim-1 proteins was essentially as described (5) Recombinant Growth Factors. Growth factors were used at the concentrations given, unless indicated otherwise. Recombinant human Ib6 and l'b7, 10 ng/ml, recombinant human Ib8, 50 ng/ml, and rat SCF 164, 10 ng/ml, were gifts of Amgen Biologicals. Recombinant mouse MGF, 22 ng/ml, was a gift of Immunex. Recombinant human IL-lcx (33), 100 U/ml, was donated by A. Stern (Hoffmann-La Roche, Nutley, NJ). Recombinant mouse Ib9 (34), 5 ng/ml, was a gift of Jacques van Snick (Ludwig Institute, Brussels, Belgium). Media from L929b cells, gift of T. M. Dexter (Paterson Institute, Manchester, UK), were used at 20% as a source of murine M-CSF, CM from X63 cell lines producing IL-3 and I1.,5 (30) , used at 1%, were donated by A. Strasser, whereas mouse Ib7-producing 3T3 cells, whose CM was used at 10%, were donated by A. Rolink (35) . Recombinant mouse leukemia inhibitory factor (ESGRO) was purchased from Amrad (Kew, Australia) and used at 1,000 U/ml, recombinant human insulin-like growth factor 1 (IGF-1) used at 10 ng/ml, was purchased from Boehringer Mannheim (Mannheim, Germany).
Results

B Cell Populations in Bone Marrow.. Comparison of the total number of bone marrow cells recovered from Pim-1 mutants
and their wild-type controls revealed no significant differences. Flow cytometric analysis of the B lymphoid populations present in the bone marrow of the various Pim-1 mutant mice showed no clear differences in pre-B cells (B220 aat slg-) (Table 1) . Also, a more detailed analysis (36) did not reveal differences (20) . Differences were noted in the size of the mature B cell compartment (B220bns ht slg +) present in El~-Pim-1 transgenic mice, which was reduced to half of that seen in wild-type mice (Table 1) . Pim-l-deficient mice did not differ from their wild-type littermates in this respect. ozygotes, homozygous Pim-l-null mutant mice were both outbred (n = 6) and inbred (n = 2). * Calls ( x 10-7) isolated from both femurs and tibiae. * Percent total bone marrow. Bone Marrow Growth Factor Response in Colony Assays. The number of different B lymphoid colony-forming cells (CFC) present in bone marrow from mice lacking (Fig. 1 A) or overexpressing Pim-1 (Fig. 1 B) were determined. In bone marrow of Pim-l-defident mice, the number of colonies obtained with either IL-7, which induces pre-B cell colonies (28), or with IL-7 and SF, which also stimulates more primitive cells to differentiate into pre-B cells (37) , is reduced to approximately one third of wild-type levels. A reduction is also seen in colony size (see also below). In contrast, mature B cell colonies formed upon stimulation with LPS (38) are normal both in number and size.
In E#-Pim-1 transgenic mice, there is an increase in the number of colonies formed in response to the combination of IL-7 and SF. A moderate increase is seen in stimulations with IL-7 alone, whereas there is actually a decrease in the number of LPS-responsive CFC. The latter is corroborated by flow cytometry (see above). No clear effect on colony size was noted. Interestingly, homozygous transgenic mice clearly differed in the severity of their phenotype from the heterozygous mice. A similar effect has been noted for the phenotype described before for these mice. T cell lymphomagenesis, with homozygous mice displaying a much higher incidence (',~40% per yr) than heterozygous mice (5-10% per yr).
Whereas a strict correlation is seen between Pim-1 expression levels (shown below) and the number of colonies induced by IL-7 and SF (Fig. 1 C) . This is not seen for the induction of myeloid (macrophage) colonies by M-CSF (39) . A possible exception are homozygous transgenic mice, where the numbers are reduced.
The data show that in Pim-l-defident mice, the number of early, IL-7 + SF responsive, B lymphoid cells is reduced whereas the numbers of mature, LPS responsive, B cells in bone marrow are normal In mice overexpressing Pim-1 the opposite is seen, and the numbers of the IL-7 + SF responsive early B cell progenitors are increased, whereas the number of LPS-responsive B cells, is reduced.
Bone Marrow Growth Factor Response in Liquid Cultures. Because pre-B cell colonies showed differences in size, we monitored their growth potential by directly stimulating bone marrow in liquid cultures (37) . Clear differences were noted when unfractionated bone marrow from different Pim-1 mutants was stimulated with IL-7 + SF or IL-7 alone. The growth of bone marrow cells from mice heterozygous for the Pim-1 null allele was significantly reduced when compared with that of wild-type llttermates, whereas a more drastic reduction was seen with the bone marrow of homozygous null mutant mice (Fig. 2) . Subculturing (for up to several weeks) did not improve growth in the Pim-l-deficient cultures, although wild-type cultures continued to grow with similar kinetics (data not shown).
Bone marrow of E~-Pim-1 transgenic mice showed an increased response with IL-7 + SF (Fig. 2) , whereas the effect of IL-7 only did not differ significantly from those of wildtype littermates. Upon subculturing, differences in growth rate disappeared (data not shown). This indicates that the increased production initially seen reflects differences in the livin 9 cells per ml {'10 "s) number of responsive cells present in bone marrow rather than differences in growth rate. Flow cytometric analysis of the cells obtained in these cultures (Fig. 2) shows that virtually all of the cells produced are pre-B cells (B220 +, slg-). This also holds true for all Pim-1 mutant cultures, including those with a severely impaired response to IL-7, demonstrating that, as in the colony assays, Pim-I null mutants can still recognize and use IL-7.
Pim-1 Expression in Murine Pre-B Cells. To determine whether these differences correlated with the Pirn-1 protein levels, cells were harvested after 7-10 d of stimulation and the Pim-1 proteins were immunoprecipitated and labeled with np in an autophosphorylation reaction (5). As shown in Fig. 3 , the amount of Pim-1 protein detected in this way correlated with Fi gure 3. Pim-1 protein expression levels in mutant Pim-1 mice. Pim-1 levels were determined by autophosphorylatinn with 32p of the antibodyimmobilized proteins in a kinase assay. The 44-kD Pim-1 protein is overrepresented since this is a much better substrate for autophosphorylation (5). 2.5 x 106 primary pre-B cells, as in In the resulting mice, which were homozygous for the Pim-1 null allele and heterozygous for the WT-Pim-1 transgene, the IL-7 response had indeed been rescued (Fig. 4) . Flow cytometric analysis of the cultures (data not shown) confirmed the presence of the expected population of pre-B cells (B220 +, sIg-). When Pim-1 protein levels were analyzed in ceUs derived from these cultures (Fig. 4) close to normal levels of both Pim-1 proteins were seen in ceils derived from null mutant mice carrying the WT-Pirn-1 transgene. This conclusively shows that the impaired IL-7 response is caused by the absence of the Pim-1 proteins. Expression of surface markers, determined by flow cytometry, on WSC905. Similar expression patterns were seen on agar-derived clones from this cell line.
Whitlocle-Witte Type Long-Term B Lymphoid Cultures Can be Established from Mutant
cultures. There are no obvious differences between the various genotypes, showing that the differences described above cannot be seen when complex cell-cell interactions are allowed between stromal and lymphoid cells.
Characterization of Cell Lines Derived from Whitlock-Witte Cultures. We tested nonadherent cells from such cultures
for their response to various growth factors. In the absence of growth factors, and even in the presence of long-term cultures-CM, the cells died rapidly. However, in the presence of certain growth factors, rapid and continuous growth, allowing cloning in soft agar, was induced in cells derived from all four independent E#-Pim-1 transgenic cultures tested, but not from wild-type cultures (Fig. 5) . The surface markers of these cells showed a pre-B cell phenotype (Fig. 5) . No staining was observed for CDllb, GtL-1, JORO-30-8, JORO 75, CD3, CD4, and CD8. CD43 ($7) expression was either low or absent. to grow cells with a similar phenotype directly from bone marrow using the same growth factors failed. The cells are dependent on simultaneous stimulation by IL-7 and SF ( Fig. 6 A and B) . IL-7 could not be replaced by any of the other growth factor (combinations) tested. SF, however, could be replaced by IGF-1 (Fig. 6 C) , although the growth rate was less than in response to IL-7 and SF (Fig.  6 D) . IGF-1 did not further increase IL-7 + SF induced growth, unlike some other factors (Fig. 6 E) .
Interestingly, unlike what has been reported for various other progenitor B cell lines (35) , these seem to be blocked in differentiation, since attempts to induce slg expression using cocultivation with the stromal cell lines ST2, PA6, and RPO.10, in the presence or absence of IL-7 and LPS, have failed. A similar lack of differentiation was observed in vivo, when 5 x 106 cells were injected into SCID mice.
Discussion
Pim-I Expression Levels Determine the Size of B Cell Progenitor Compartments in Bone
Marrow.. Murine P/m-l, whose overexpression is associated with a variety of tumors, encodes a serine/threonine-specific protein kinase (5) . We have shown previously that aberrant levels of Pim-1 affect IL-3-induced proliferation of bone marrow-derived mast cells in vitro (21) . Here we have used mouse mutants to show that it is involved in vivo in the regulation of early steps of B lymphopoiesis. This is illustrated most clearly by the observation that the number of SF and IL-7 responsive early-B lymphoid CFC in bone marrow directly follows the expression levels of Pim-1.
The growth rate in response to these factors is impaired in the absence of Pim-1. We also found that overexpression facilitates the establishment of factor-dependent early lymphoid cell lines that seemed to be blocked in differentiation.
IL-7 is a stromal cell factor with growth-promoting activity for B cell precursors (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) . More primitive B cells require an additional stimulus, such as SF (41) (42) (43) or IGF-I (44). To identify additional important factors, mouse mutants in which the responses to known factors are impaired, can be important tools. Pim-l-deficient mice, which show a severely impaired response to IL-7 and SF, but which are capable of normal B lymphopoiesis in vivo and in LTC in vitro, will constitute an excellent model system to search for such factors.
The earliest B cell precursor compartment assayed (IL-7 + SF responsive) was the most profoundly affected. CFU-S assays on E#-Pim-1 transgenic mice have shown that this very early nonlymphoid committed, precursor population is not increased (Domen, J., E. Spooncer, and T. M. Dexter, unpublished observations), suggesting that these effects of aberrant Pim-1 expression do not extend to the most early hematopoietic cell compartment. The number of mature B cells in bone marrow (B220 +, slg § , responsive to LPS), while normal in Pim-l-deficient mice, is reduced in EIz-Pim-1 transgenic mice. A decrease in mature B cell numbers has also been observed in E/~-myc transgenic mice, here concomitant with the increase in pre-B cell numbers (45) . The absence of significant changes in the periphery of Pim-1 mutants (9, 20) may be explained by an increased life span or proliferation of relatively long-lived mature B cells (46) . This is also observed in the other null mutants with impaired B cell production, such as c-abl (47) and )~5 mice (48) . The lack of correlation between the size of the pre-B cell compartment as defined by flow cytometry and the number of CFC present suggests that only a distinct subset of the pre-B cells are clonogenic precursors. The total number of pre-B cells in the bone marrow may be limited through other mechanisms, like the available bone marrow space.
Intriguingly, in marrows with the highest Pim-1 expression, a reduction in M-CSF responsive ceils is observed. This reduction may reflect a selective differentiation of common precursors, such as described for fetal liver (49) , towards the lymphoid lineages, or a more direct effect on macrophage differentiation, e.g., by affecting common mediators specific for the SF and M-CSF response.
Defects Caused by the Targeted Disruption of Pim-1 Locus Can be Rescued in Trans. The defects seen in the null mutant mice are likely caused by the inactivation of Pira-1, as the same phenotype has been observed in mice obtained from different, independently targeted, ES cell clones. However, in order to formally prove that the phenotype observed was the result of Pim-1 inactivation, we introduced a wild-type Pim-1 transgene. This transgene indeed rescued the effects seen, which can thus be completely ascribed to Pim-1.
Pim-1 Functions in a Dose-dependent Fashion. Pim-1 exerts its function in a dose-dependent manner, over a large dosage range, both in the assays described and in lymphoma incidence. Dosage-dependent phenotypes are displayed by some protein kinases, like regulators of mitosis in yeast (50) , sometimes despite the presence of redundantly acting proteins (51) , whereas the activity of other kinases, e.g., most protooncogenes, is strictly regulated (52) . The highly inducible and short-lived RNA (11-13) and extremely short protein half-life (5) suggest, in line with the dosage-dependence seen, that Pim-1 might function as a constitutively active enzyme, although it cannot be excluded that activation is required, but not rate limiting.
Implications for the Function of Pim-l, The in vitro analysis ofB lymphopoiesis in the Pim-1 mutant mice presented here has shown for the first time that Pim-1 is involved in the responses to different growth factors which act on early B-lymphoid compartments. Absence of Pim-1 does not lead to a total lack of responsiveness to the early B-lymphoid growth factors IL-7 and SF, whereas overexpression does not abrogate factor dependency, similar to the effects noted for IL-3 (21). This is unlike what has been reported for protein tyrosine kinases which can abrogate growth factor dependency (53) , indicating that Pim-1 is a modulator rather than a mediator for the response to these factors. Whereas Pim-l-deficient cells show reduced growth rates when propagated in the presence of IL-7 or IL-3, we have not observed increased growth rates in cells overexpressing Pim-1. This suggests that Pim-1 levels in wild-type cells are already saturating for the proliferation-inducing signals. However, this does not seem to be in agreement with the phenotype of overexpression in vivo, an increasing tendency to develop lymphomas. Therefore, regulation of the size of early compartments by Pim-1 probably does not reflect a direct involvement in the proliferative response to growth factors. More likely, Pira-1 is involved in transducing signals that can halt or impair differentiation. This would explain the coincidence of Pim-1 levels and early B-lymphoid colony forming capacity of bone marrow and the behavior of cell lines obtained from overexpressors. It would also explain how Pim-1 functions as an oncogene when overexpressed, as expanded progenitor pools would increase the size of the cell compartment critically important to the accumulation of mutations. Detailed biochemical analysis is needed to fully resolve the mechanism of action of the Pim-1 proteins. Furthermore, it remains to be determined ifPim-1 fulfills a similar function in the T cell lineage. The involvement of Pim-1 in T cell lymphomagenesis indicates that this is probably the case.
